MétaCan
Menu
← Back to cohort
Record W2586764620 · doi:10.1093/ecco-jcc/jjx002.466

P341 Combination of corticosteroids and 5-aminosalycilates or corticosteroids alone for patients with moderate-severe active ulcerative colitis: a global survey of physicians' practice

2017· article· en· W2586764620 on OpenAlexaff
Shomron Ben‐Horin, Jane M. Andrews, Κωνσταντίνος Κατσάνος, Florian Rieder, Flávio Steinwurz, Konstantinos Κarmiris, Jae Hee Cheon, Gordon W. Moran, Monica Cesarini, Christian D. Stone, Doron Schwartz, Marijana Protić, Xavier Roblin, Giulia Roda, M. Chen, Ofir Har‐Noy, Çharles N. Bernstein

Bibliographic record

VenueJournal of Crohn s and Colitis · 2017
Typearticle
Languageen
FieldBiochemistry, Genetics and Molecular Biology
TopicInflammatory Bowel Disease
Canadian institutionsUniversity of Manitoba
Fundersnot available
KeywordsMedicineLikert scaleUlcerative colitisFamily medicineClinical PracticeInternal medicinePsychology

Abstract

fetched live from OpenAlex

Background: There are sparse data on whether 5-aminosalicylates (5ASA) confer additional benefit when combined with corticosteroids (CS) in active ulcerative colitis (UC). We examined gastroenterologists' approach toward this management decision Methods: A cross-sectional questionnaire exploring physicians' attitude toward 5ASA+CS combination therapy versus CS alone was developed and validated. The questionnaire was distributed to gastroenterology experts in twelve countries in five continents. Respondents' agreement with stated treatment choices were assessed by standardized Likert scale. Background professional characteristics of respondents were analyzed for correlation with responses Results: 664 questionnaires were distributed and 349 received (52.6% response rate). Of these, 340 were eligible respondents from 12 countries (Figure 1). In total, 221 (65%) would continue 5ASA in a patient hospitalized for intravenous CS treatment due to a moderate-severe UC flare, while 108 (32%) would stop the 5ASA (p<0.001), and 11 (3%) are undecided (Figure 2). Similarly, 62% would continue 5ASA in an out-patient starting oral CS. However, only 140/340 (41%) would proactively start 5ASA in a hospitalized patient not receiving 5ASA before admission. Most (97%) physicians consider the safety profile of 5ASA as very good. Only 52% consider them inexpensive, 35% perceive them to be expensive and 12% are undecided. On multi-variable analysis, less years of practice and perception of a plausible additive mechanistic effect of 5ASA+CS were positively associated with the decision to continue 5ASA with CS. Figure 1. Distribution of countries of practice among the responding physicians. Figure 2. Continue 5ASA in a hospitalized steroid-treated patient. Conclusions: Despite the absence of supporting evidence, the majority of gastroenterologists endorse combination of 5ASA + corticosteroids for patients with active moderate-to-severe UC, although practices vary greatly among clinicians. Randomized controlled trials are needed to assess if 5ASA confer any benefit for these patients.

Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.

How this classification was reachedexpand

Full frame machine prediction

Teacher imitation

Not calibrated prevalence, not ground truth. Human validation pending. The Gemma side is a direct model label for every work in the frame, read from the title-only record. The Codex side is a classifier learned from the 10,348 direct Codex labels and calibrated to design-weighted sample rates; fields without enough sample support carry no Codex call. Candidate is the union of the two sides; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels.

metaresearch head score (Codex)0.002
metaresearch head score (Gemma)0.004
Version: metacan-v3-hybrid-931329e0061cValidation status: machine_predicted_unvalidated
Candidate categoriesnone
Consensus categoriesnone
DomainCandidate signal: none · Consensus signal: none
Study designCandidate signal: Observational · Consensus signal: Observational
GenreCandidate signal: Empirical · Consensus signal: Empirical
Teacher disagreement score0.002
Threshold uncertainty score0.009

Distilled classifier scores by category (both heads)

CategoryCodexGemma
Metaresearch0.0020.004
Meta-epidemiology (narrow)0.0000.000
Meta-epidemiology (broad)0.0000.000
Bibliometrics0.0010.001
Science and technology studies0.0000.000
Scholarly communication0.0000.001
Open science0.0000.000
Research integrity0.0010.000
Insufficient payload (model declined to judge)0.0020.000

Machine scores (provisional)

The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.

Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.

Opus teacher head0.011
GPT teacher head0.270
Teacher spread0.259 · how far apart the two teachers sit on this one work
Validation statusscore_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from it

Classification

machine, unvalidated

Machine predicted; a candidate call from one source (direct Gemma or distilled Codex), not a consensus.

The models applied no category: nothing in the taxonomy fit this work.
Study designObservational
Domainnot available
GenreEmpirical

How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".

Quick stats

Citations0
Published2017
Admission routes1
Has abstractyes

Explore more

Same venueJournal of Crohn s and Colitis→Same topicInflammatory Bowel Disease→French-language works237,207→